SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-08-001541
Filing Date
2008-03-14
Accepted
2008-03-14 10:23:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 KERYX BIOPHARMACEUTICALS, INC. p08-0726sc13g.txt SC 13G 97529
  Complete submission text file 0000902664-08-001541.txt   99703
Mailing Address 885 THIRD AVENUE NEW YORK NY 10022
Business Address 885 THIRD AVENUE NEW YORK NY 10022 2124464020
DAVIDSON KEMPNER PARTNERS (Filed by) CIK: 0000928549 (see all company filings)

IRS No.: 133393346
Type: SC 13G

Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78786 | Film No.: 08687980
SIC: 2834 Pharmaceutical Preparations